Enovis Corp Stock Performance
| ENOV Stock | USD 39.43 0.42 1.08% |
The firm shows a Beta (market volatility) of 1.27, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Enovis Corp will likely underperform. At this point, Enovis Corp has a negative expected return of -0.12%. Please make sure to confirm Enovis Corp's jensen alpha, skewness, as well as the relationship between the Skewness and day typical price , to decide if Enovis Corp performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Enovis Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors. ...more
Actual Historical Performance (%)
One Day Return 0.44 | Five Day Return 8.17 | Year To Date Return (11.56) | Ten Year Return (52.53) | All Time Return 8.4 |
Last Split Factor 581:1000 | Last Split Date 2022-04-05 |
1 | Acquisition by Angela Lalor of 513 shares of Enovis Corp subject to Rule 16b-3 | 12/31/2024 |
2 | Enovis Announces Leadership Change to International Surgical Business | 01/17/2025 |
3 | Vanguard Group Incs Strategic Acquisition of Enovis Corp Shares | 02/07/2025 |
4 | Disposition of 6599 shares by Daniel Pryor of Enovis Corp at 43.89 subject to Rule 16b-3 | 02/14/2025 |
5 | Enovis plans CEO succession | 02/26/2025 |
6 | Enovis Corporation Q4 2024 Earnings Call Transcript | 02/27/2025 |
7 | Medical Gas and Equipment Market is expected to generate a revenue of USD 5.01 Billion by 2032, Globally, at 7.9 percent CAGR Verified Market Research | 02/28/2025 |
8 | Enovis Corp Announces Participation in Upcoming Investor Conferences | 03/05/2025 |
9 | Acquisition by Bradley Tandy of 13275 shares of Enovis Corp subject to Rule 16b-3 | 03/07/2025 |
10 | Disposition of 1276 shares by Bradley Tandy of Enovis Corp at 36.62 subject to Rule 16b-3 | 03/10/2025 |
11 | What is Scotiabanks Forecast for TSECFX FY2025 Earnings | 03/12/2025 |
12 | Acquisition by Bradley Tandy of 6366 shares of Enovis Corp subject to Rule 16b-3 | 03/13/2025 |
13 | How Is Enovis Corporation Managing Its Financial and Business Strategy | 03/18/2025 |
| Begin Period Cash Flow | 44.8 M |
Enovis |
Enovis Corp Relative Risk vs. Return Landscape
If you would invest 4,312 in Enovis Corp on December 20, 2024 and sell it today you would lose (369.00) from holding Enovis Corp or give up 8.56% of portfolio value over 90 days. Enovis Corp is currently does not generate positive expected returns and assumes 2.3403% risk (volatility on return distribution) over the 90 days horizon. In different words, 20% of stocks are less volatile than Enovis, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Enovis Corp Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Enovis Corp's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Enovis Corp, and traders can use it to determine the average amount a Enovis Corp's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0532
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ENOV |
Estimated Market Risk
| 2.34 actual daily | 20 80% of assets are more volatile |
Expected Return
| -0.12 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Enovis Corp is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Enovis Corp by adding Enovis Corp to a well-diversified portfolio.
Enovis Corp Fundamentals Growth
Enovis Stock prices reflect investors' perceptions of the future prospects and financial health of Enovis Corp, and Enovis Corp fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Enovis Stock performance.
| Return On Equity | -0.28 | ||||
| Return On Asset | 0.0073 | ||||
| Profit Margin | (0.39) % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 3.59 B | ||||
| Shares Outstanding | 56.96 M | ||||
| Price To Earning | 9.48 X | ||||
| Price To Book | 0.87 X | ||||
| Price To Sales | 1.05 X | ||||
| Revenue | 2.11 B | ||||
| EBITDA | (827.42 M) | ||||
| Cash And Equivalents | 358.68 M | ||||
| Cash Per Share | 6.63 X | ||||
| Total Debt | 72.49 M | ||||
| Debt To Equity | 0.15 % | ||||
| Book Value Per Share | 45.86 X | ||||
| Cash Flow From Operations | 113.5 M | ||||
| Earnings Per Share | (14.98) X | ||||
| Total Asset | 4.72 B | ||||
| Retained Earnings | (283.02 M) | ||||
About Enovis Corp Performance
Evaluating Enovis Corp's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Enovis Corp has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Enovis Corp has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Enovis Corporation operates as a medical technology company worldwide. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies and directly under the DJO brand. Enovis Corp operates under Specialty Industrial Machinery classification in the United States and is traded on New York Stock Exchange. It employs 16200 people.Things to note about Enovis Corp performance evaluation
Checking the ongoing alerts about Enovis Corp for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Enovis Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Enovis Corp generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 2.11 B. Net Loss for the year was (824.82 M) with profit before overhead, payroll, taxes, and interest of 1.25 B. | |
| Over 99.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from kalkinemedia.com: How Is Enovis Corporation Managing Its Financial and Business Strategy |
- Analyzing Enovis Corp's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Enovis Corp's stock is overvalued or undervalued compared to its peers.
- Examining Enovis Corp's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Enovis Corp's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Enovis Corp's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Enovis Corp's stock. These opinions can provide insight into Enovis Corp's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Enovis Stock Analysis
When running Enovis Corp's price analysis, check to measure Enovis Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enovis Corp is operating at the current time. Most of Enovis Corp's value examination focuses on studying past and present price action to predict the probability of Enovis Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enovis Corp's price. Additionally, you may evaluate how the addition of Enovis Corp to your portfolios can decrease your overall portfolio volatility.